ÇѽŰæ¸é¿ªÇÐȸ 2024³â ÇÏ°èÇмú´ëȸ : 2024-08-17
±³À°ÀÏÀÚ : 2024-08-17
±³À°Àå¼Ò : ¼¿ï º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ë (¿ÀÇÁ¶óÀÎ °³ÃÖ)
±³À°ÁÖÁ¦ : ´ëÇѽŰæ¸é¿ªÇÐȸ 2024³â ÇÏ°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ¸é¿ªÇÐȸ
´ã´çÀÚ : ´ëÇѽŰæ¸é¿ªÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-720-1594
À̸ÞÀÏ : ksms1594@naver.com
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 90,000¿ø
ºñ°í »çÀüµî·Ï: Àü°øÀÇ ¹«·á, Àü¹®ÀÇ,±âŸ(ȸ¿ø) 4¸¸¿ø, ºñȸ¿ø 8¸¸¿ø / ´çÀϵî·Ï: Àü°øÀÇ ¹«·á, Àü¹®ÀÇ,±âŸ(ȸ¿ø) 5¸¸¿ø, ºñȸ¿ø 9¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 09:30~09:55 Updates in NMOSD and MOGAD ±è±âÈÆ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 09:55~10:20 Updates in multiple sclerosis ÀÌÇý¸²(°í·ÁÀÇ´ë)
Åä·Ð 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 10:20~10:30 Q&A ¼¼¼Ç¿¬ÀÚ ¸ðµÎ()
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 10:40~11:00 Radiologically Isolated Syndrome and MS prodrome ±èÁöÀº(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 11:00~11:20 Intergrating serum neurofilament light chain into clinical practice: The next frontiers in MS disease activity and prognosis assessment ±è¼öÇö(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 11:20~11:40 Emerging Cell Therapies in mutiple sclerosis ¼®Áø¸í(¼øõÇâÀÇ´ë)
Åä·Ð 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 11:40~11:50 Q&A ¼¼¼Ç¿¬ÀÚ ¸ðµÎ()
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 11:50~12:30 Invited lecture : Microbiome in Neurodegenerative Disease ¹¬ÀÎÈñ(¼¿ï´ëÇб³)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 13:00~13:30 Scientific session ¥°(Neuroimmunology & Multiple Sclerosis (MS)) ¹ÎÁÖÈ«(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 13:30~14:00 Special Session: Sharing experience for networking and research ½ÅÇÏ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 14:00~15:00 Scientific session ¥± (Neuroimmunology & Multiple Sclerosis (MS)) ¿ÀÁö¿µ, ±èº´Á¶(°Ç±¹ÀÇ´ë, °í·ÁÀÇ´ë)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 15:15~15:35 Role of B cell in Multiple sclerosis ±èÇöÁø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 15:35~15:55 B cell depletion treatments for multiple sclerosis: Real-world data ±Ç¿µ³²(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 15:55~16:15 Bruton tyrosine kinase inhibitors for multiple sclerosis ±Ç¼ø¿í(ÀÎÇÏÀÇ´ë)
Åä·Ð 08¿ù 17ÀÏ º¸ÄÚ¼¿ï°³² LLÃþ(B2) º¼·ëȦ 16:15~16:25 Q&A ¼¼¼Ç¿¬ÀÚ ¸ðµÎ()